Federal award
KBR WYLE SERVICES, LLC
0097
Contract
Obligated and Ceiling
- Obligated (net)
- $19,810,155.94
- Ceiling (potential value, not spending)
- $22,711,619.39
- Current value
- $22,711,619.39
- Gross positive obligations
- $21,333,087.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 1700
- Product or service (PSC)
- R425 · SUPPORT- PROFESSIONAL: ENGINEERING/TECHNICAL
- Industry (NAICS)
- 541330 · ENGINEERING SERVICES
- PIID
- 0097
- Parent vehicle (IDV PIID)
- N0042103D0015
- Award type code
- C
- Actions
- 22 · Dec 28, 2010 to Sep 14, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 14, 2018 | FY2018 | 1A | C | −$146,787.22 | |
| Apr 24, 2013 | FY2013 | 20 | C | −$116,616.16 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 13, 2013 | FY2013 | 19 | C | −$699,800.58 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 27, 2012 | FY2013 | 18 | B | $896,239.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 11, 2012 | FY2012 | 17 | C | $1,469,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 7, 2012 | FY2012 | 16 | C | −$366,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 14, 2012 | FY2012 | 15 | C | −$95,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 24, 2012 | FY2012 | 14 | C | $652,880.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 30, 2012 | FY2012 | 13 | C | $5,132,399.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 15, 2011 | FY2012 | 12 | G | $2,231,225.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 22, 2011 | FY2011 | 11 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 12, 2011 | FY2011 | 10 | C | $1,400,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 29, 2011 | FY2011 | 9 | C | $955,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 17, 2011 | FY2011 | 8 | C | $3,130,377.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 26, 2011 | FY2011 | 7 | C | $1,220,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 5, 2011 | FY2011 | 6 | C | $892,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 31, 2011 | FY2011 | 5 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 17, 2011 | FY2011 | 4 | C | −$98,727.10 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 25, 2011 | FY2011 | 3 | C | $995,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 7, 2011 | FY2011 | 2 | C | $330,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 28, 2011 | FY2011 | 1 | C | $250,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 28, 2010 | FY2011 | 0 | — | $1,778,967.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.